World Heart Corporation Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	37
ISBN Number	not applicable
Product Code	GMD04686

Price

£505.00
approximately: $750 | €594

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a World Heart Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - Cardiovascular Devices
3 World Heart Corporation Pipeline Products
- 3.1 World Heart Corporation Product Pipeline Analysis
  - 3.1.1 World Heart Corporation Pipeline Products By Equipment Type
  - 3.1.2 World Heart Corporation Pipeline Products By Development Stage
  - 3.1.3 World Heart Corporation Pipeline Products By Therapy Area
  - 3.1.4 World Heart Corporation Pipeline Products By News Summary
- 3.2 Levacor Rotary VAD
  - 3.2.1 Product Description
  - 3.2.2 Product Status
  - 3.2.3 Product Milestone
- 3.3 Novacor II LVAS Pulsatile VAD
  - 3.3.1 Product Description
  - 3.3.2 Product Status
  - 3.3.3 Product Milestone
  - 3.3.4 Product Patent Details
- 3.4 Pediaflow Pediatric VAD
  - 3.4.1 Product Description
  - 3.4.2 Product Status
- 3.5 HeartQuest
  - 3.5.1 Product Description
  - 3.5.2 Product Status
- 3.6 HeartSaver
  - 3.6.1 Product Description
  - 3.6.2 Product Status
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
- 10.1 Head Office
- 10.2 Other Locations & Subsidiaries
11 Financial Deals Landscape
- 11.1 Acquisition
  - 11.1.1 World Heart Acquires Medquest
- 11.2 IPO
  - 11.2.1 World Heart Completes $14.1 Million Private Placement Financing
- 11.3 Debt Offerings
  - 11.3.1 World Heart Completes Private Placement
12 Recent Developments
- 12.1 Strategy and Business Planning
  - 12.1.1 Dec 19, 2007: WorldHeart Enters Strategic Alliance With Abiomed
- 12.2 Financial Announcements
  - 12.2.1 Nov 14, 2007: WorldHeart Declares Q3 2007 Results
  - 12.2.2 Aug 08, 2007: WorldHeart Reports Q2 2007 Results
  - 12.2.3 May 21, 2007: WorldHeart Announces Reverse Stock Split
  - 12.2.4 May 14, 2007: WorldHeart Reports Q1 2007 Results
  - 12.2.5 Apr 09, 2007: WorldHeart Elects New Board Member
  - 12.2.6 Mar 27, 2007: WorldHeart Reports Q4 2006 Results
  - 12.2.7 Nov 14, 2006: WorldHeart Reports Q3 2006 Results
- 12.3 Other Significant Developments
  - 12.3.1 Aug 31, 2007: WorldHeart Appoints New CFO
  - 12.3.2 Nov 22, 2006: WorldHeart Receives Notice From Nasdaq
13 Appendix
- 13.1 Methodology
  - 13.1.1 Coverage
  - 13.1.2 Secondary Research
  - 13.1.3 Primary Research
  - 13.1.4 Expert Panel Validation
- 13.2 Contact Us
- 13.3 About Global Markets Direct
- 13.4 Disclaimer
List of Tables
- Table 1: World Heart Corporation,Key Facts
- Table 2: World Heart Corporation Pipeline Products by Equipment Type
- Table 3: World Heart Corporation Pipeline Products By Development Stage
- Table 4: World Heart Corporation Pipeline Products By Therapy Area
- Table 5: World Heart Corporation Pipeline Products By News Summaries
- Table 6: World Heart Corporation, Key Employees,
- Table 7: World Heart Corporation, Subsidiaries
List of Figures
- Figure 1: Global Markets Direct Methodology